OncoHost

OncoHost Presents New Research Revealing Biological Drivers of TKI Sensitivity in Metastatic Renal Cell Carcinoma at ESMO 2026

OncoHost, a technology company transforming the approach to predictive precision diagnostics for improved patient outcomes, today announced new…